Cargando…

Efficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed Rats

BACKGROUND: Hypercholesterolemia is one of the most important risk factors for atherosclerosis and subsequent cardiovascular diseases. OBJECTIVE: The present work was aimed to study the efficacy of curcuminoid fraction from Curcuma xanthorrhiza and its curcuminoid cider in reducing blood cholesterol...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauren, Flavia Maria, Yanti, Lay, Bibiana Widiati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908841/
https://www.ncbi.nlm.nih.gov/pubmed/27365981
http://dx.doi.org/10.4103/0974-8490.181468
_version_ 1782437752750473216
author Mauren, Flavia Maria
Yanti,
Lay, Bibiana Widiati
author_facet Mauren, Flavia Maria
Yanti,
Lay, Bibiana Widiati
author_sort Mauren, Flavia Maria
collection PubMed
description BACKGROUND: Hypercholesterolemia is one of the most important risk factors for atherosclerosis and subsequent cardiovascular diseases. OBJECTIVE: The present work was aimed to study the efficacy of curcuminoid fraction from Curcuma xanthorrhiza and its curcuminoid cider in reducing blood cholesterol level and four genes related to oxidative stress, including cluster of differentiation 44 (CD44), intercellular adhesion molecule 1 (ICAM-1), inducible nitric oxide synthase (iNOS), and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in high-cholesterol fed rats in vivo. MATERIALS AND METHODS: Twenty-four male Sprague-Dawley rats were divided into six groups, namely normal group diet, high-cholesterol diet (HCD) 2%, HCD + 100 mg/kg b.w. curcuminoid fraction, HCD + 300 mg/kg b.w. curcuminoid fraction, HCD + cider 1% v/v, and HCD + curcuminoid cider 2% v/v for 4 weeks. Total cholesterol levels were measured at day 1, 14, and 28. Vascular tissues and organs from lung and liver were collected for RNA extraction, followed by quantitative analysis using real-time polymerase chain reaction (PCR). RESULTS: Our results demonstrated that among all the treatment groups, curcuminoid cider at 2% v/v significantly lowered total cholesterol level compared to those of positive control. Real-time PCR data showed both curcuminoid fractions (100 and 300 mg/kg) and curcuminoid cider (1 and 2% v/v) inhibited the gene expression of CD44, ICAM-1, iNOS, and LOX-1, indicating their hypocholesterolemic effects via attenuating genes related to oxidative stress in rats in vivo. CONCLUSION: Oral administration of curcuminoid fraction and its cider product may exert potential inhibitory effects on oxidative stress related-genes for preventing hypercholesterolemia-induced atherosclerosis in vivo. SUMMARY: Curcuminoid and its cider significantly inhibited the gene expression of CD44, ICAM-1, iNOS, and LOX-1 in rats in vivo. Curcuminoid and its cider suppressed oxidative stress-related genes inducing formation of atherosclerosis. Curcuminoid and its cider may offer cardioprotective effect for preventing hypercholesterolemia-induced atherosclerosis. [Image: see text] Abbreviations Used: ROS: Reactive oxygen species, NO: Nitric oxide, NOS: NO synthase, NADPH: Nicotinamide adenine dinucleotide phosphate, CD44: Cluster of differentiation 44, ICAM-1: Intercellular adhesion molecule 1, iNOS: inducible NOS, LOX-1: lectin-like oxidized LDL receptor-1, HMG-CoA: 3-hydroxy-3-methylglutaryl-coenzyme A, 5-HMF: 5-hydroxymethylfurfural, HCD: High-cholesterol diet
format Online
Article
Text
id pubmed-4908841
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49088412016-07-01 Efficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed Rats Mauren, Flavia Maria Yanti, Lay, Bibiana Widiati Pharmacognosy Res Original Article BACKGROUND: Hypercholesterolemia is one of the most important risk factors for atherosclerosis and subsequent cardiovascular diseases. OBJECTIVE: The present work was aimed to study the efficacy of curcuminoid fraction from Curcuma xanthorrhiza and its curcuminoid cider in reducing blood cholesterol level and four genes related to oxidative stress, including cluster of differentiation 44 (CD44), intercellular adhesion molecule 1 (ICAM-1), inducible nitric oxide synthase (iNOS), and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in high-cholesterol fed rats in vivo. MATERIALS AND METHODS: Twenty-four male Sprague-Dawley rats were divided into six groups, namely normal group diet, high-cholesterol diet (HCD) 2%, HCD + 100 mg/kg b.w. curcuminoid fraction, HCD + 300 mg/kg b.w. curcuminoid fraction, HCD + cider 1% v/v, and HCD + curcuminoid cider 2% v/v for 4 weeks. Total cholesterol levels were measured at day 1, 14, and 28. Vascular tissues and organs from lung and liver were collected for RNA extraction, followed by quantitative analysis using real-time polymerase chain reaction (PCR). RESULTS: Our results demonstrated that among all the treatment groups, curcuminoid cider at 2% v/v significantly lowered total cholesterol level compared to those of positive control. Real-time PCR data showed both curcuminoid fractions (100 and 300 mg/kg) and curcuminoid cider (1 and 2% v/v) inhibited the gene expression of CD44, ICAM-1, iNOS, and LOX-1, indicating their hypocholesterolemic effects via attenuating genes related to oxidative stress in rats in vivo. CONCLUSION: Oral administration of curcuminoid fraction and its cider product may exert potential inhibitory effects on oxidative stress related-genes for preventing hypercholesterolemia-induced atherosclerosis in vivo. SUMMARY: Curcuminoid and its cider significantly inhibited the gene expression of CD44, ICAM-1, iNOS, and LOX-1 in rats in vivo. Curcuminoid and its cider suppressed oxidative stress-related genes inducing formation of atherosclerosis. Curcuminoid and its cider may offer cardioprotective effect for preventing hypercholesterolemia-induced atherosclerosis. [Image: see text] Abbreviations Used: ROS: Reactive oxygen species, NO: Nitric oxide, NOS: NO synthase, NADPH: Nicotinamide adenine dinucleotide phosphate, CD44: Cluster of differentiation 44, ICAM-1: Intercellular adhesion molecule 1, iNOS: inducible NOS, LOX-1: lectin-like oxidized LDL receptor-1, HMG-CoA: 3-hydroxy-3-methylglutaryl-coenzyme A, 5-HMF: 5-hydroxymethylfurfural, HCD: High-cholesterol diet Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4908841/ /pubmed/27365981 http://dx.doi.org/10.4103/0974-8490.181468 Text en Copyright: © Pharmacognosy Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mauren, Flavia Maria
Yanti,
Lay, Bibiana Widiati
Efficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed Rats
title Efficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed Rats
title_full Efficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed Rats
title_fullStr Efficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed Rats
title_full_unstemmed Efficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed Rats
title_short Efficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed Rats
title_sort efficacy of oral curcuminoid fraction from curcuma xanthorrhiza and curcuminoid cider in high-cholesterol fed rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908841/
https://www.ncbi.nlm.nih.gov/pubmed/27365981
http://dx.doi.org/10.4103/0974-8490.181468
work_keys_str_mv AT maurenflaviamaria efficacyoforalcurcuminoidfractionfromcurcumaxanthorrhizaandcurcuminoidciderinhighcholesterolfedrats
AT yanti efficacyoforalcurcuminoidfractionfromcurcumaxanthorrhizaandcurcuminoidciderinhighcholesterolfedrats
AT laybibianawidiati efficacyoforalcurcuminoidfractionfromcurcumaxanthorrhizaandcurcuminoidciderinhighcholesterolfedrats